Midwives Revision

Infectious Diseases

Onchocerciasis

A chronic parasitic disease caused by the filarial nematode Onchocerca volvulus, transmitted by the bite of infected blackflies (Simulium species) that breed in fast-flowing rivers. Affects skin and eyes, major cause of blindness.

Also known as: River Blindness

View images for Onchocerciasis (Google Images, opens in a new tab)
On this page

Referral and warning signs

When to refer

Refer suspected cases for diagnosis confirmation (skin snip). Refer for management initiation (Ivermectin/Doxycycline). Refer ALL patients with eye symptoms or visual impairment to Ophthalmology (RR) urgently. Refer patients from Loa loa endemic areas for risk assessment before Ivermectin.

Red flags

  • Any visual symptom (blurring, floaters, pain, photophobia).
  • Signs of severe skin inflammation or secondary infection.
  • Neurological symptoms after Ivermectin (suspect Loa loa reaction).

Signs and symptoms

  • Skin Manifestations:
  • - Onchocercomas (Nodules): Firm, non-tender, subcutaneous nodules containing adult worms. Usually over bony prominences (iliac crests, ribs, head, sacrum).
  • - Pruritus: Intense itching, often earliest and most troublesome symptom.
  • - Acute Papular Onchodermatitis (APOD): Itchy papular rash.
  • - Chronic Papular Onchodermatitis (CPOD): Larger, flatter, itchy papules.
  • - Lichenified Onchodermatitis (LOD): Hyperpigmented, thickened, scaling, severely itchy plaques ('lizard skin', 'elephant skin').
  • - Atrophy: Thinning, wrinkled skin ('presbyderma').
  • - Depigmentation: Patchy loss of pigment ('leopard skin'), often over shins.
  • Ocular Manifestations (River Blindness): Due to microfilariae migrating into eye.
  • - Conjunctivitis, photophobia.
  • - Punctate keratitis (snowflake opacities - reversible).
  • - Sclerosing keratitis (progressive corneal scarring -> blindness).
  • - Anterior uveitis / Iridocyclitis.
  • - Glaucoma.
  • - Chorioretinitis (inflammation of choroid/retina).
  • - Optic atrophy.
  • Leading to progressive, irreversible visual impairment and blindness.

Risk factors

  • Living near fast-flowing rivers where Simulium blackflies breed.
  • Occupations involving river exposure (farming, fishing).
  • Residence in endemic areas (Sub-Saharan Africa, Latin America, Yemen).

Diagnosis

Clinical assessment

Suspicion based on characteristic skin lesions (nodules, itching, pigment changes) and/or eye symptoms in person from endemic area.

Differential diagnosis

  • Skin: Scabies, Insect bites, Eczema, Fungal infections, Lichen planus, Leprosy, Lymphoma cutis, Vitiligo.
  • Eye: Other causes of keratitis, uveitis, blindness (Trachoma, Cataract, Glaucoma).

Investigations

  • Skin Snip Biopsy: Gold standard. Small, superficial skin shaving (usually from iliac crest or calf), incubated in saline, examined under microscope for emerging microfilariae. Multiple snips increase sensitivity.
  • Nodule Excision: Palpable nodules can be excised and examined for adult worms (confirmatory but not routine).
  • Slit Lamp Examination: Ophthalmologist can visualize microfilariae swimming in the anterior chamber or cornea.
  • Patch Test (Mazzotti Test): Application of DEC patch causes localized reaction (itching/rash) if microfilariae present (rarely used now due to systemic reaction risk with oral DEC).
  • Antibody tests (limited utility for active infection).
  • PCR on skin snips (research/specialized labs).

Diagnostic criteria

Clinical suspicion + Confirmation by identifying microfilariae in skin snip OR visualization in eye OR adult worms in nodule.

Management

Non-pharmacological management

  • Management of itching (antihistamines, emollients).
  • Surgical removal (nodulectomy) of easily accessible nodules may reduce adult worm burden but not curative.
  • Management of visual impairment (low vision aids).

Pharmacological treatment

  • Microfilaricidal Treatment (Mainstay - kills microfilariae, reduces symptoms/transmission, prevents eye disease progression):
  • - Ivermectin 150 mcg/kg PO single dose. Repeated every 6-12 months. Treatment is long-term (10-15 years or more) due to long lifespan of adult worms. (LOC: HC3+ / MDA Programs)
  • - Caution: DO NOT use Ivermectin if high suspicion of co-infection with Loa loa (another filarial worm endemic in Central/West Africa) due to risk of severe encephalopathy. Assess Loa loa risk before treating.
  • Adulticidal Treatment (Kills adult worms):
  • - Doxycycline 100-200mg PO daily for 4-6 weeks. Targets Wolbachia endosymbiont bacteria necessary for adult worm survival and embryogenesis. Leads to gradual death/sterility of adult worms. Often given before or with Ivermectin. (LOC: HC3+ / Specialist)
  • - Suramin (older drug, toxic, requires IV, rarely used now).
  • - Moxifloxacin (potential future role).
  • Management of Reactions: Mazzotti reaction (fever, rash, itching, adenitis after Ivermectin) usually mild, manage with antihistamines/analgesics. Steroids rarely needed.

Monitoring

Monitor symptoms (itching, skin lesions, vision). Monitor adherence to long-term Ivermectin treatment. Assess Loa loa co-infection risk before starting Ivermectin in relevant areas.

Complications

  • Severe chronic itching -> Skin damage, secondary infections.
  • Disfiguring skin changes (atrophy, depigmentation, lichenification).
  • Visual impairment / Blindness.
  • Social stigma, economic impact.
  • Severe adverse reactions to treatment (esp. if Loa loa co-infection).

Prevention

  • Mass Drug Administration (MDA): Community-directed treatment with Ivermectin (CDTI) annually or semi-annually in endemic areas.
  • Vector Control: Larviciding of blackfly breeding sites in rivers (historically successful in West Africa).
  • Personal protection (repellents, protective clothing - limited effectiveness).

Patient education

  • Explanation of Onchocerciasis cause (blackfly bite, worm infection).
  • Chronic nature of disease.
  • Importance of long-term Ivermectin treatment (prevents blindness, reduces itching/skin disease).
  • Potential side effects of Ivermectin (Mazzotti reaction).
  • Skin care for itching/dryness.
  • Importance of eye check-ups.
  • Role of MDA in controlling disease in community.

Uganda-specific notes

Endemic in specific foci associated with fast-flowing rivers (e.g., Mt Elgon region, West Nile, Western Uganda). CDTI programs are main control strategy. Eye complications are significant. Loa loa co-infection is NOT typically a major concern in Ugandan foci.

References

  • Uganda Clinical Guidelines (UCG) 2023

    Chapter 2, Section 2.4.5

  • National Onchocerciasis Control Programme Guidelines, MOH Uganda

    (Specific program documents)

For learning and professional reference. Use current local guidance and clinical judgement.

Browse all conditions

Want notes in PDF? Join our classes!!

Send us a message on WhatsApp
0726113908

Scroll to Top